News | July 22, 2023
Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin
Good momentum in commercial CDMO business
Good momentum in commercial CDMO business
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
This transformation will enable GE HealthCare to build a strong foundation for business growth
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
First of its kind screening for Glaucoma at grass root level over 10k screened already
Subscribe To Our Newsletter & Stay Updated
